Source:http://linkedlifedata.com/resource/pubmed/id/18484082
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-1-27
|
pubmed:abstractText |
Variability in antidepressant response is due to genetic and environmental factors. Among genetic factors, the ones controlling for availability of the drug at the target site are interesting candidates. Rs6295C/G SNP in the 5-HT1A gene (HTR1A) has been found to affect the expression and function of HTR1A. In fact rs6295C/G is in strong linkage disequilibrium with other polymorphisms of HTR1A suggesting that those functional effects could be associated with polymorphisms other than or together with the synonymous rs6295C/G. In the present study we examined the possible association of a panel of markers in strong linkage disequilibrium of the HTR1A with SSRI/SNRI response in 137 Japanese major depression subjects followed for 6 weeks. We observed a significant association of better response to antidepressant in rs10042486C/C (P < 0.0001), rs6295G/G (P < 0.0001) and rs1364043T/T (P = 0.018) genotype carriers (minor allele homozygotes), independently from clinical variables. Furthermore minor allele homozygous carriers in all these three SNPs were associated with treatment response by various assessment such as HAM-D score change over time (P = 0.001), week 2 (P < 0.0001), 4 (P = 0.007), and 6 (P = 0.048) as well as response rate (P = 0.0005) and remission rate (P = 0.004). We also pointed out the genotyping mis-definition of rs6295C/G in the previous four articles. In conclusion, this is the first study that reports a significant association of antidepressant response with rs10042486C/T and rs1364043T/G variants of HTR1A and also with rs10042486-rs6295-rs1364043 combination. This finding adds an important information for the pathway of detecting the genetics of antidepressant response even if results must be verified on larger samples.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1552-485X
|
pubmed:author |
pubmed-author:AzumaJunichiJ,
pubmed-author:FukudaTsuyoshiT,
pubmed-author:HosoiYukaY,
pubmed-author:KatoMasakiM,
pubmed-author:KinoshitaToshihikoT,
pubmed-author:OkugawaGakuG,
pubmed-author:SerrettiAlessandroA,
pubmed-author:TakekitaYoshiteruY,
pubmed-author:WakenoMasatakaM,
pubmed-author:WatanabeSyunsukeS,
pubmed-author:YamashitaMegumiM
|
pubmed:copyrightInfo |
2008 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
5
|
pubmed:volume |
150B
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-23
|
pubmed:meshHeading |
pubmed-meshheading:18484082-Antidepressive Agents, Second-Generation,
pubmed-meshheading:18484082-Base Sequence,
pubmed-meshheading:18484082-DNA Primers,
pubmed-meshheading:18484082-Depressive Disorder, Major,
pubmed-meshheading:18484082-Humans,
pubmed-meshheading:18484082-Linkage Disequilibrium,
pubmed-meshheading:18484082-Polymorphism, Single Nucleotide,
pubmed-meshheading:18484082-Receptor, Serotonin, 5-HT1A,
pubmed-meshheading:18484082-Serotonin Uptake Inhibitors
|
pubmed:year |
2009
|
pubmed:articleTitle |
Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.
|
pubmed:affiliation |
Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan. masaki.kato@unibo.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|